| 生物活性 |
Frexalimab (SAR441344) is a second-generation monoclonal antibody targeting the CD40 ligand (CD40L) with a good safety profile. Frexalimab inhibits the binding between CD40 and CD40L to modulate immune response. Frexalimab is likely to help prevent the process of β-cell destruction. Frexalimab is proming for multiple sclerosis, lupus erythematosus, Sj gren’s syndrome and type I diabetes research.
|
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 分子量 |
145.698 kDa
|
||||||||||||
| CAS号 |
2515463-86-0
|
||||||||||||
| 中文名称 |
Frexalimab
|
||||||||||||
| 运输条件 |
Shipping with dry ice.
|
||||||||||||
| 储存方式 |
|
纯度： 99%
关注我们
获得KKL MED 最新资讯
咨询热线：
400-881-9290
Data Sheet